Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05006378 · ClinicalTrials.gov registry record · NA
Effect of Chamomile Intake on Blood Coagulation Tests in Healthy Volunteers
A NA study, sponsored by Stony Brook University.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT05006378 is a NA study that has completed, run by Stony Brook University. The registered enrollment target is 12 participants.
The verdict
NCT05006378, a NA study, has completed, sponsored by Stony Brook University.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
Chamomile may possess anticoagulant effects based on the presence of coumarin-like compounds within the flower. This randomized, placebo-controlled complete crossover study will investigate the impact of chamomile ingestion on coagulation.
Interventions
- DIETARY_SUPPLEMENT Placebo Capsule
- DIETARY_SUPPLEMENT Chamomile Tea
- DIETARY_SUPPLEMENT Chamomile Extract Capsule
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2021-08-31 |
| Est. Completion | 2022-01-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05006378
The ClinicalTrials.gov registry entry for NCT05006378 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stony Brook University, which has 127 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo Capsule is the first listed.
NCT05006378 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05006378 about?
NCT05006378 is a clinical study titled "Effect of Chamomile Intake on Blood Coagulation Tests in Healthy Volunteers". Chamomile may possess anticoagulant effects based on the presence of coumarin-like compounds within the flower. This randomized, placebo-controlled complete crossover study will investigate the impact of chamomile ingestion on coagulation.
What is the current status of trial NCT05006378?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2021-08-31. Estimated completion is 2022-01-19.
What interventions are being tested in trial NCT05006378?
The interventions under investigation include: Placebo Capsule (DIETARY_SUPPLEMENT), Chamomile Tea (DIETARY_SUPPLEMENT), Chamomile Extract Capsule (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05006378?
This trial is sponsored by Stony Brook University, which has 127 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.